Organisational and Structural Drivers of Childhood Immunisation in the European Region: A Systematic Review.
expanded program on immunisation
mandatory immunisation policy
national immunisation programme
primary health care
strategic advisory group of experts on immunisation
vaccination coverage
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
25 Aug 2022
25 Aug 2022
Historique:
received:
16
07
2022
revised:
17
08
2022
accepted:
18
08
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
24
9
2022
Statut:
epublish
Résumé
Despite the implementation of widespread vaccination programs, the European Health Systems continue to experience care challenges attributable to organizational and structural issues. This study aimed to review the available data on aspects within the organizational and structural domains that might impact vaccination coverage. We searched a comprehensive range of databases from 1 January 2007 to 6 July 2021 for studies that reported quantitative or qualitative research on interventions to raise childhood vaccine coverage. Outcome assessments comprised organizational and structural factors that contribute to vaccine concern among pediatric parents, as well as data reported influencing the willingness to vaccinate. To analyze the risk of bias, the Ottawa, JBI's (Joanna Briggs Institute) critical appraisal tool, and Amstar quality assessment were used accordingly. The inclusion criteria were met by 205 studies across 21 articles. The majority of the studies were conducted in the United Kingdom (6), the European Union (3), and Italy (3). A range of interventions studied in primary healthcare settings has been revealed to improve vaccination coverage rates including parental engagement and personalization, mandatory vaccination policies, program redesign, supply chain design, administering multiple/combination vaccines, improved vaccination timing and intervals, parental education and reminders, surveillance tools and Supplemental Immunisation Activity (SIA), and information model.
Identifiants
pubmed: 36146467
pii: vaccines10091390
doi: 10.3390/vaccines10091390
pmc: PMC9505321
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Epidemiol Community Health. 2016 Nov;70(11):1082-1087
pubmed: 27177579
Euro Surveill. 2017 Apr 27;22(17):
pubmed: 28488999
BMC Infect Dis. 2015 Dec 29;15:585
pubmed: 26714777
Isr J Health Policy Res. 2016 Feb 01;5:2
pubmed: 26839681
Vaccine. 2019 Oct 8;37(43):6486-6493
pubmed: 31522808
Lancet. 2021 Jan 30;397(10272):398-408
pubmed: 33516338
Vaccine. 2013 Sep 13;31(40):4293-304
pubmed: 23859839
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1495-1500
pubmed: 34710074
Vaccine. 2020 Dec 3;38(51):8130-8135
pubmed: 33162205
Thorax. 2010 Sep;65(9):770-4
pubmed: 20805169
JAMA Pediatr. 2022 Jan 1;176(1):68-77
pubmed: 34617975
BMC Public Health. 2015 Sep 02;15:836
pubmed: 26328551
Vaccine. 2018 Aug 23;36(35):5340-5347
pubmed: 30055970
CMAJ. 2011 Jun 14;183(9):E535-6
pubmed: 21576291
Front Pharmacol. 2019 Aug 30;10:948
pubmed: 31543816
Vaccines (Basel). 2022 Mar 07;10(3):
pubmed: 35335036
BMC Public Health. 2015 Aug 19;15:798
pubmed: 26285702
Lancet Infect Dis. 2015 May;15(5):535-43
pubmed: 25801458
Hum Vaccin Immunother. 2018 Apr 3;14(4):875-880
pubmed: 29252094
Hum Vaccin Immunother. 2013 Aug;9(8):1802-11
pubmed: 23807361
BMC Public Health. 2013 Oct 02;13:908
pubmed: 24083352
Pediatrics. 2020 Feb;145(2):
pubmed: 31932361
Vaccine. 2015 Jun 9;33(25):2862-80
pubmed: 25944299
Euro Surveill. 2014 Sep 04;19(35):
pubmed: 25210983
Euro Surveill. 2018 Apr;23(17):
pubmed: 29717696
BMC Nurs. 2017 Jun 12;16:31
pubmed: 28615990
Vaccine. 2016 Jul 29;34(35):4103-4109
pubmed: 27349841
Ann Ig. 2019 May-Jun;31(3):191-201
pubmed: 31069364
Euro Surveill. 2012 Apr 26;17(17):
pubmed: 22551498
Scand J Public Health. 2020 Feb;48(1):96-105
pubmed: 30024308
AJOB Empir Bioeth. 2021 Oct-Dec;12(4):253-265
pubmed: 34328070
Soc Sci Med. 2006 Feb;62(3):628-42
pubmed: 16039769
Hum Vaccin Immunother. 2013 Dec;9(12):2672-3
pubmed: 24084386
Vaccine. 2020 Jul 14;38(33):5163-5170
pubmed: 32576461
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Eur J Pediatr. 2019 Feb;178(2):243-251
pubmed: 30430239
Vaccine. 2010 Jun 11;28(26):4235-48
pubmed: 20438879
BMC Med. 2019 May 17;17(1):86
pubmed: 31096986
Cent Eur J Public Health. 2016 Jun;24(2):133-6
pubmed: 27434245
Paediatr Drugs. 2017 Feb;19(1):69-80
pubmed: 28035545
Vaccines (Basel). 2020 Oct 08;8(4):
pubmed: 33049956
JRSM Short Rep. 2011 Oct;2(10):81
pubmed: 22046500
Vaccine. 2016 Feb 3;34(6):723-34
pubmed: 26706274
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Nov;52(11):1099-104
pubmed: 19841874
Big Data. 2015 Jun 1;3(2):59-66
pubmed: 26487984
Vaccine. 2015 Aug 14;33(34):4204-11
pubmed: 25900132
Vaccine. 2021 Dec 20;39(52):7584-7589
pubmed: 34802784
Hum Vaccin. 2008 Jul-Aug;4(4):313-5
pubmed: 18398297
Cochrane Database Syst Rev. 2014 Nov 19;(11):CD010232
pubmed: 25408540
Vaccine. 2018 Sep 18;36(39):5811-5818
pubmed: 30143274
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
Infect Dis Now. 2020 Oct 12;51(2):153-158
pubmed: 33059002
Pediatrics. 2015 Jul;136(1):70-9
pubmed: 26034240
Vaccine. 2021 Jun 29;39(29):3935-3939
pubmed: 34116875
Hum Vaccin Immunother. 2018 Jul 3;14(7):1558-1565
pubmed: 29641945
Bull World Health Organ. 2019 Nov 01;97(11):754-763
pubmed: 31673191
Lancet. 2021 Aug 7;398(10299):503-521
pubmed: 34273291
Acta Paediatr. 2021 Sep;110(9):2529-2535
pubmed: 34028088
Vaccine. 2018 Aug 16;36(34):5150-5159
pubmed: 30041880
Int J Environ Res Public Health. 2018 Apr 03;15(4):
pubmed: 29614056
Eur J Public Health. 2020 Jun 1;30(3):449-455
pubmed: 31642905
Ital J Pediatr. 2018 Jun 14;44(1):67
pubmed: 29898770
BMC Fam Pract. 2016 Jul 30;17:101
pubmed: 27475527
PLoS Biol. 2015 Aug 07;13(8):e1002227
pubmed: 26252770
Pediatrics. 2012 Sep;130(3):e600-6
pubmed: 22908102